5,875 followers
New Research: Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system #pharmacology https://t.co/z8imhzRsor
New Research: Post-marketing safety surveillance of dalfampridine for multiple sclerosis using FDA adverse event reporting system #pharmacology https://t.co/z8imhzRsor